Accessibility Menu
Hims & Hers Health logo

Hims & Hers Health(NYSE) HIMS

Market Cap$6.39BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2019)+192%
5 Year+302%
1 Year-39%
1 Month-17%
$27.42
-4.16%
-1.19Today
After hours$27.38-$0.04 (-0.15%)
Hims & Hers Health last closing stock price
MetricPriceDate
Last closeUSD 27.392026-08-18
Hims & Hers Health stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-10.23%USD 30.512026-08-11
1 month-16.6%USD 32.842026-07-17
3 month+18.88%USD 23.042026-05-20
Year to date-15.65%USD 32.472025-12-31
1 year-39.27%USD 45.102025-08-18
3 year+302.2%USD 6.812023-08-18
5 year+302.2%USD 6.812021-08-19
Since inception+191.94%USD 9.802019-09-13

Hims & Hers Health Financials at a Glance

Market Cap

$6.39BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$2.58B

Net Income (TTM)

-$142.03M

EPS (TTM)

-$0.62

P/E Ratio

-43.96

Dividend

$0.00

Beta (Volatility)

1.93 (High)

Price

$27.42

Volume

7,932,261

Open

$27.85

Previous Close

$27.39

Daily Range

$27.38 - $28.85

52-Week Range

$13.74 - $65.30

Estimated Earnings Date

Nov 9, 2026

HIMS: Motley Fool Moneyball Superscore

73

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Hims & Hers Health

Hims & Hers Health, Inc. helps people get medical care online. It connects patients with doctors for virtual health and wellness visits. Customers can order medications for hair, skin, and sexual health.

What's in the Medicine Cabinet?

  • United States Revenue: Sales and services provided to domestic customers; accounted for $621.8 million of total revenue for the three-month period ended June 30, 2026.
  • Rest of the World Revenue: International sales and services through entities in regions including Europe and Australia; accounted for $131.4 million of total revenue for the three-month period ended June 30, 2026.
  • Subscription Services: Recurring plans for medications and wellness products; accounts for a substantial majority of the company's online sales.
  • Weight Loss: Personalized health programs providing access to both branded and compounded medications plus provider support.

Growing the Global Footprint

  • Acquired Eucalyptus in June 2026 to expand operations into Australia and Japan.
  • Merged with YourBio in Jan. 2026 to incorporate blood-sampling technology into its portfolio.
  • Completed the purchase of Zava in July 2025 to grow its European presence.
  • Launched a membership program for weight loss medications in the United States in March 2026.

More Than Just a Website

The company operates a vertically integrated model by managing its own pharmacies and manufacturing facilities to fulfill orders. Its digital platform combines electronic medical records with a network of licensed healthcare providers to streamline patient care.

Results From the Ledger

  • Total revenue was $753.2 million for the three-month period ended June 30, 2026, up 38% year over year.
  • Subscriber count rose to approximately 2.9 million as of June 30, 2026, a 19% increase year over year.
  • Gross margin was 64% for the six-month period ended June 30, 2026.
  • Net loss was $86.3 million for the three-month period ended June 30, 2026.

The Evolution of Care

Hims & Hers has evolved from a niche telehealth provider into a global digital platform with a broad health and wellness portfolio. Its transition into specialized care and internal manufacturing supports a scalable model for long-term health services.

AI Generated • Aug 11, 2026

Industry

Healthcare Providers and Services

Employees

2,442

CEO

Andrew Dudum

Headquarters

San Francisco, CA 94123, US

HIMS Financials

Key Financial Metrics (TTM)

Gross Margin

64.68%

Operating Margin

-3.59%

Net Income Margin

-5.51%

Return on Equity

-30.03%

Return on Capital

6.36%

Return on Assets

-3.91%

Earnings Yield

-2.27%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$6.39BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

233.31M

Volume

7.93M

Avg. Volume

16.29M

Financials (TTM)

Gross Profit

$1.67B

Operating Income

-$92.67M

EBITDA

-$76.42M

Operating Cash Flow

$266.84M

Capital Expenditure

-$176.96M

Free Cash Flow

$89.89M

Cash & ST Invst.

$841.05M

Total Debt

$1.55B

Hims & Hers Health Performance Analysis

Hims & Hers Health annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 526,916,00093.8%
20232023-12-31USD 872,000,00065.5%
20242024-12-31USD 1,476,514,00069.3%
20252025-12-31USD 2,347,637,00059.0%
Hims & Hers Health sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-309.9%
Q42025-12-313.1%
Q12026-03-31-1.6%
Q22026-06-3023.9%
Hims & Hers Health annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.32-44.3%
20232023-12-31USD -0.11-65.0%
20242024-12-31USD 0.53N/A
20252025-12-31USD 0.51-3.7%
Hims & Hers Health sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-62.7%
Q42025-12-3126.2%
Q12026-03-31-600.0%
Q22026-06-307.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$753.21M

+38.2%

Gross Profit

$480.80M

+15.5%

Gross Margin

63.83%

N/A

Market Cap

$6.39BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$2.62M

N/A

Employees

2,442

N/A

Net Income

-$86.29M

-303.0%

EBITDA

-$63.16M

-245.8%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$841.05M

-26.5%

Total Debt

$1.55B

+48.1%

Accounts Receivable

$375.29M

+5472.2%

Inventory

$87.78M

-38.1%

Long Term Debt

$1.53B

+47.4%

Short Term Debt

$11.55M

+84.2%

Return on Assets

-3.91%

N/A

Return on Invested Capital

-4.32%

N/A

Free Cash Flow

-$55.39M

+20.2%

Operating Cash Flow

-$35.94M

-88.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HQYHealthEquity, Inc.
$102.79+0.45%
QGENQiagen N.V.
$42.32-0.66%
ENSGThe Ensign Group, Inc.
$182.49+0.53%
TECHBio-Techne Corporation
$72.22-0.23%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.48-0.02%
INTCIntel
$96.69-0.07%
NOKNokia
$10.39-0.04%
NVDANvidia
$219.74-0.02%

Questions About HIMS

What is the current price of Hims & Hers Health?

Hims & Hers Health is trading at $27.39 per share.

What is the 52-week range for Hims & Hers Health?

Over the past 52 weeks, Hims & Hers Health has traded between $13.74 and $65.30.

How much debt does Hims & Hers Health have?

As of the most recent reporting period, Hims & Hers Health reported total debt of $1.55B.

How much cash does Hims & Hers Health have on hand?

Hims & Hers Health reported $609.81M in cash and cash equivalents in its most recent financial results.

What is Hims & Hers Health’s dividend yield?

Hims & Hers Health does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.